Patents by Inventor Andrew C. Williams

Andrew C. Williams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11543202
    Abstract: A tracker for a firearm comprises a device capable of being secured to a Picatinny® rail of a firearm. The device is in wireless communication with a smart electronic device thereby alerting a user of when the firearm has been moved. The device also comes with an audio alert which issues forth a high decibel and painful sound to dissuade unauthorized use.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: January 3, 2023
    Inventor: Andrew C. Williams
  • Patent number: 5576325
    Abstract: The invention provides pharmaceutical compounds of the formula: ##STR1## in which A - - - B is CH.sub.2 --CH.sub.2 or CH.dbd.CH;X is a pyridine or benzene ring;when X is pyridine n is 0;when X is benzene n is 0, 1 or 2 and when A - - - B is CH.sub.2 --CH.sub.2, R.sup.1 is attached at any of the positions 7 to 10, and when A - - - B is CH.dbd.CH, R.sup.1 is attached at any of the positions 5 to 10;each R.sup.1 is halo, carboxy, trifluoromethyl, hydroxy, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, hydroxy-C.sub.1-4 alkyl, hydroxy-C.sub.1-4 alkoxy, nitrogen-containing heterocyclyl, nitro, trifluoromethoxy, --COOR.sup.5 where R.sup.5 is an alkyl group, --COR.sup.6, --CONR.sup.6 R.sup.7 or --NR.sup.6 R.sup.7 where R.sup.6 and R.sup.7 are each hydrogen or C.sub.1-4 alkyl;R.sup.2 is phenyl, naphthyl or heteroaryl selected from thienyl, pyridyl, benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, said phenyl, naphthyl and heteroaryl groups being optionally substituted, or R.sup.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 19, 1996
    Assignee: Lilly Industries Limited
    Inventor: Andrew C. Williams
  • Patent number: 5574034
    Abstract: The invention provides pharmaceutical compounds of the formula: ##STR1## in which A - - - B is CH.sub.2 --CH.sub.2 or CH.dbd.CH;X is a pyridine or benzene ring;when X is pyridine n is 0;when x is benzene n is 0, 1 or 2 and when A - - - B is CH.sub.2 --CH.sub.2. R.sup.1 is attached at any of the positions 7 to 10, and when A - - - B is CH.dbd.CH, R.sup.1 is attached at any of the positions 5 to 10;each R.sup.1 is halo, carboxy, trifluoromethyl, hydroxy, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, hydroxy-C.sub.1-4 alkyl, hydroxy-C.sub.1-4 alkoxy, nitrogen-containing heterocyclyl, nitro, trifluoromethoxy, --COOR.sup.5 where --R.sup.5 is an ester group, --COR.sup.6, --CONR.sup.6 R.sup.7 or --NR.sup.6 R.sup.7 where R.sup.6 and R.sup.7 are each hydrogen or C.sub.1-4 alkyl;R.sup.2 is phenyl, naphthyl or heteroaryl selected from thienyl, pyridyl, benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, said phenyl, naphthyl and heteroaryl groups being optionally substituted, or R.sup.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 12, 1996
    Assignee: Eli Lilly and Company
    Inventor: Andrew C. Williams
  • Patent number: 5571818
    Abstract: The invention provides pharmaceutical compounds of the formula: ##STR1## in which A-B is CH.sub.2 --CH.sub.2 or CH.dbd.CH; X is a pyridine or benzene ring;when X is pyridine n is 0;when X is benzene n is 0, 1 or 2 and when A-B is CH.sub.2 --CH.sub.2, R.sup.1 is attached at any of the positions 7 to 10, and when A-B is CH.dbd.CH, R.sup.1 is attached at any of the positions 5 to 10;each R.sup.1 is halo, carboxy, trifluoromethyl, hydroxy, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, hydroxy-C.sub.1-4 alkyl, hydroxy-C.sub.1-4 alkoxy, nitrogen-containing heterocyclyl, nitro, trifluoromethoxy, --COOR.sup.5 where R.sup.5 is an alkyl group, --COR.sup.6, --CONR.sup.6 R.sup.7 or --NR.sup.6 R.sup.7 where R.sup.6 and R.sup.7 are each hydrogen or C.sub.1-4 alkyl;R.sup.2 is phenyl, naphthyl or heteroaryl selected from thienyl, pyridyl, benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, said phenyl, naphthyl and heteroaryl groups being optionally substituted, or R.sup.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 5, 1996
    Assignee: Eli Lilly and Company
    Inventor: Andrew C. Williams
  • Patent number: 5514699
    Abstract: The invention provides pharmaceutical compounds of the formula: ##STR1## in which A - - - B is CH.sub.2 --CH.sub.2 or CH.dbd.CH;X is a pyridine or benzene ring;when X is pyridine n is 0;when X is benzene n is 0, 1 or 2 and when A - - - B is CH.sub.2 --CH.sub.2, R.sup.1 is attached at any of the positions 7 to 10, and when A - - - B is CH.dbd.CH, R.sup.1 is attached at any of the positions 5 to 10;and salts thereof.
    Type: Grant
    Filed: March 21, 1994
    Date of Patent: May 7, 1996
    Assignee: Lilly Industries Limited
    Inventor: Andrew C. Williams
  • Patent number: 5434160
    Abstract: Pharmaceutical compound of the formula ##STR1## R.sup.1 is phenyl or heteroaryl selected from thienyl, pyridyl, benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, said phenyl and heteroaryl groups being optionally substituted, or R.sup.1 is furanyl optionally substituted with C.sub.1-4 alkyl;R.sup.2 is nitrile, carboxy, --COOR.sup.4 where R.sup.4 is an ester group, --CONR.sup.5 R.sup.6 where R.sup.5 and R.sup.6 are each hydrogen or C.sub.1-4 alkyl, or R.sup.7 SO.sub.2 -- where R.sup.7 is C.sub.1-4 alkyl or optionally substituted phenyl;R.sup.3 is --NR.sup.8 R.sup.9, --NHCOR.sup.8, --N(COR.sup.8).sub.2, --N.dbd.CHOR.sup.8 where R.sup.8 and R.sup.9 are each hydrogen or C.sub.1-4 alkyl, or --NHSO.sub.2 R.sup.10 where R.sup.10 is C.sub.1-4 alkyl or optionally substituted phenyl; or ##STR2## where X is C.sub.2-4 alkylene; and the group ##STR3## represents a pyridine ring fused to the benzopyran nucleus; and salts thereof.
    Type: Grant
    Filed: November 12, 1993
    Date of Patent: July 18, 1995
    Assignee: Lilly Industries Limited
    Inventors: Colin P. Dell, Andrew C. Williams